I have had dups for about five years. I have often read this board but never posted before on it. I am getting to point where I have to do something. Then today I received this article on a google alert. I would likle to know if anyone knows if this has any validity, or is it just to good to be true.

HealthSonix Develops New Treatment Protocols for Dupuytren's Contracture; Patients Show Positive Results

IRVINE, CA -- (MARKET WIRE) -- May 15, 2007 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced that it has achieved successful results in the treatment of patients with Dupuytren's Contracture using its sound pulse technology.

Dupuytren's Contracture, a disease of the palmar fascia, results in the thickening and shortening of fibrous bands in the hands and fingers. The incidence of Dupuytren's contracture is highest in Caucasians, historically those of Celtic descent. It most often affects the ring or little finger, sometimes both, and often in both hands. Although the exact cause is unknown it is genetic in nature, meaning it runs in families. This condition is seven times more common in men than women. The disorder may occur suddenly but more commonly progresses slowly over a period of years. The disease usually doesn't cause symptoms until after the age of 40.

Without treatment, such as surgical intervention, the Contracture can become so severe that the patient cannot straighten his/her finger, and eventually they may not be able to use their hand effectively.

Highlighted Links
AquaSonix

"We were quite pleasantly surprised by the fact that our sound pulses were able to relieve some of the stiffness and in some cases even restore mobility," said Dr. David Venturi, Medical Director of HealthSonix. "More clinical work will commence shortly to further study and expand on treatment outcomes," added Dr. Venturi.

HealthSonix sound pulse technology has now been made available for home use in the state of the art, self-administered enSonix@home medical device. The enSonix@home device will be available online May 22, 2007, when the company launches its new online store: www.MyArthritisStore.com

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core products are based on proprietary, patent pending medical technologies that use sound pulses to stimulate soft tissue, muscles and sensory and mechanoreceptors in the human body to relieve pain. All pain relief treatments and products are safe, non-invasive, and have no known side effects.

More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this news release are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a nu

For their technology to be of any significant value it would need to be able to lengthen or dissolve the Dups Collagen tissue that pulls fingers toward the palm. However, having read their web site claims they tend to stress pain relief. While that in itself may be significant for arthritis, our shared disease has nothing to do with joint pain but with the growth of rogue Collagen in the palm and fingers.

Let them present the data. I don't even need or require double blind placebo. Just release of bent fingers in a significant number of cases and I'll be on board. Otherwise.....

Yes, NA and Collegenase injections are essentially interchangeable procedures. They both weaken the cord just enough to snap it as the doctor pulls back on the finger or palm contractions. NA uses a needle (mechanical) while Collegenase dissolves the cord biochemically. Open Surgery may later be done if these do not work.

Collegenase may have the potential to reach and dissolve Dups material that NA can't touch. The dissolving of nodules would be a possibility, though no one has yet proposed this.

But, NA is available *now* and is proven safe and effective. Collegenase is years away and by all accounts cost far more. What you have to marvel at is how few CHS are doing NA. They all seem to be sitting back waiting for Collegenase and doing what may now be unnecessary traditional invasive Open Surgery. While OS may be necessary in some cases, there is no reason to start there and ignore the far less invasive NA as the first option of choice.

peterm: if you are interested in new therapies you might also have a look at http://www.dupuytren-online.info/other_therapies.html
Wolfgang

Quote:

---

... At least someone looked at something for dups. I still hope for better options than we now have. ...

---

Recurrence is always a difficult question, sure it depends on the time frame that you look at. With collagenase there is still too little experience, specifically long term, to make reliable statements about recurrence.

The 2-3 years until approval by FDA is only a guess. We have been believeing that it is 2-3 years down the road for the last five years ... time will tell.

Wolfgang

Quote:

---

Thanks Wolfgang. I did not no that recurrence with collagenase was so low.
Further, if it is 2 or 3 year until approval by the FDA, is the clock ticking now because some were injected before the trial was stopped, or is it 2 or 3 years for approval after they resume the trial? Is it possible that the new drug could be approved in another country before it is approved in the U.S.?

Thanks in advance for any assistance

---